NovoCure Ltd Balance Sheet
NVCR / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
NovoCure Ltd had $804M in total assets and $340M in shareholders' equity as of FY2025. Total debt was $195M against $94M in cash, resulting in $101M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93.5M | $163.8M | $240.8M | $115.3M | $208.8M | $234.7M | $177.3M | $140.6M | $78.6M | $99.8M | $119.4M | $57.6M | $175.9M |
| Accounts Receivable | $89.4M | $74.2M | $61.2M | $86.3M | $93.6M | $96.7M | $58.9M | $36.5M | $29.6M | $6.3M | $0 | - | - |
| Inventory | $41.1M | $35.1M | $38.2M | $29.4M | $24.4M | $27.4M | $23.7M | $22.6M | $22.0M | $25.5M | $13.6M | $3.4M | - |
| Current Assets | $646.7M | $1.1B | $1.0B | $1.1B | $1.1B | $999.4M | $439.9M | $321.4M | $245.1M | $261.9M | $293.9M | $111.8M | - |
| PP&E (Net) | $77.6M | $77.7M | $51.5M | $32.7M | $22.7M | $11.4M | $9.3M | $8.4M | $9.0M | $9.8M | $6.6M | $3.7M | - |
| Total Assets | $804.3M | $1.2B | $1.1B | $1.2B | $1.1B | $1.1B | $479.4M | $339.8M | $265.3M | $282.1M | $307.3M | $117.9M | - |
| Current Liabilities | $223.2M | $756.4M | $179.1M | $158.8M | $142.6M | $113.6M | $86.3M | $64.6M | $50.2M | $36.9M | $28.6M | $17.7M | - |
| Total Debt | $195.0M | $97.3M | $568.8M | $565.5M | $562.2M | $429.9M | $149.4M | $149.3M | $97.3M | $96.2M | $23.1M | $0 | - |
| Shareholders' Equity | $340.5M | $360.2M | $362.5M | $441.2M | $410.5M | $476.5M | $217.8M | $112.3M | $113.6M | $142.3M | $250.8M | $97.9M | $171.8M |